# Rebalance Execution Plan Production Trial Exam

Generated: 2026-07-01T07:27:53

## Executive Summary

- Result: PASS
- Main finding: Rebalance Plan v0.1 correctly caps migration under anomaly / stale data and allows only controlled migration in normal pullback assumptions.
- Safe for daily Production Trial use: YES

## Scenario Results

| Scenario | Expected | Actual | Result | Notes |
| --- | --- | --- | --- | --- |
| A — Extreme Uptrend / Anomaly | Severe -> max 0-5%; Warning -> conservative cap; CDE authorization and user confirmation required. | Severe anomaly; Execution Blocked; Migration Authority cap 0-5%. | PASS | Real domestic snapshot used. No direct action language. CDE and user confirmation preserved. |
| B — Normal Pullback / Controlled Migration | Normal pullback with controlled CDE may allow 5-10% or 10-20% staged migration. | Normal anomaly; None; Migration Authority 10-20%; staged tiers required. | PASS | Documented mock only. No fake provider data written. Execution Readiness remains input only. |
| C — Missing / Stale Market Data | Missing / stale data should be Unknown or Severe, block or cap at 0-5%, and avoid precise authority. | Severe anomaly; Execution Blocked; Migration Authority cap 0-5%. | PASS | Documented mock only. Conservative framework required; no direct action recommendation. |

## Boundary Verification

| Boundary | Result |
| --- | --- |
| No CDE formula modification | PASS |
| No strategy logic modification | PASS |
| No portfolio file modification | PASS |
| No private amounts stored | PASS |
| No new Engine | PASS |
| No automatic trading | PASS |
| No Buy / Sell language as Atlas action | PASS |

## Final Decision

SAFE FOR DAILY PRODUCTION TRIAL
